Heyholder

This is an amended filing

‹ Activism Filings

GI Innovation Inc. Received USD 3.5 million milestone fee from Maruho of Japan for GI301

GI Innovation Inc.

AI summary · Not investment advice

GI Innovation received a USD 3.5 million milestone fee from Japan's Maruho on Nov 16, 2026, after the first patient was dosed in a Phase 2 trial in Japan.

Commentary

AI commentary · Not investment advice

What happened

GI Innovation received a technology fee of USD 3,500,000 from Maruho of Japan. The fee is tied to a milestone: the first patient was dosed in a Phase 2 clinical trial in Japan. It is paid under a license contract the two companies signed earlier.

In the company's terms

This filing is a correction. Before the correction, the company said it expected payment within 60 days after issuing the invoice. The correction sets the actual receipt date as November 16, 2026. The materials give about KRW 4.6 billion at an exchange rate of 1,324.60 won per USD.

What changes for shareholders

For scale, the company's revenue last year was KRW 5.84 billion. The materials do not give a ratio comparing the fee with that revenue.

Comments

No comments yet

Comments from shareholders will appear here.